A prospective open-label extension study (to study 99784) of gaboxadol in primary insomnia
Latest Information Update: 24 Jul 2007
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Adverse reactions; Registrational
- 18 Nov 2005 New trial record.